November 11th, 2015
This protocol describes how to generate induced pluripotent stem cells (iPSCs) from human peripheral T cells in feeder-free conditions using a combination of matrigel and Sendai virus vectors containing reprogramming factors.
The overall goal of this procedure is to generate induced pluripotent stem cells or IPCs from human peripheral T cells in feeder free conditions. This method can help answer key questions in the field of regenerative medicine, including how IPS cells can be applied into clinical use. The main advantage of this technique is that IPS cells can be cured without the inclusion of possible harm refactor, which reduces the risk of pathogenicity.
The implication of this technique extends world clinically relevant IPS cell-based therapies because of the, this invasive cell sampling combined with reduce risk of exposing the development IPS cells to undefined pathogens. So this method can provide insight into IPS service clinical therapy. It can also be applied to other areas such as disease modeling conditions.
Begin preparing activated human T cells by diluting 10 milliliters of heparinized whole blood with 10 milliliters of DPBS pipette. 15 milliliters of fol solution into a 50 milliliter conical tube. Slowly pipette the diluted blood running along the inside wall of the tube to layer on top of the solution.
Be careful not to disturb the interface. Centrifuge the tube at 400 times G for 30 minutes at room temperature. After centrifugation, observe three layers, including a lower clear layer, a thin white layer containing mononuclear cells and an upper milky plasma layer.
Transfer the mononuclear cell layer to a new 50 milliliter conical tube without transferring any fit hole solution. Next, add DPBS to bring the total volume to 10 milliliters. Centrifuge the tube at 200 times G for five minutes at room temperature.
Discard the supernatant, wash the cells with 10 milliliters of DPBS centrifuge the tube at 200 times G for five minutes and remove the supernatant. Then add one milliliter of KBM 5 0 2 medium to the cells and count using a hemo cytometer to prepare the cell culture dish coat the wells of a six well plate with 10 micrograms per milliliter of anti-human CD three antibody solution in PBS. Incubate the plate at 37 degrees Celsius and 5%carbon dioxide for at least 30 minutes.
After incubation, remove the antibody solution from the plate eight and wash once with PBS seed the mononuclear cells at a density of 2.5 times 10 to the fifth cells per square centimeter in a total volume of two milliliters of KBM 5 0 2 medium in the coated six well plates incubate the cells for three to seven days without changing the medium, at which point the T-cell should reach con fluency following the three to seven days. Transfer the activated T-cells with a medium to a 15 milliliter conical tube and centrifuge at 200 times G for five minutes. Remove the SNAT and add one milliliter of fresh KBM 5 0 2 medium.
Count the cells and plate 1.5 times 10 to the six cells in two milliliters of KBM 5 0 2 medium into each well of an anti CD three antibody coated six well plate next thaw the OC three SOX two, KLF four, and C-M-Y-C-H, and L sendi virus solutions on ice at each engineered Sendai virus individually to each well and a multiplicity of infection of 10. Incubate at 37 degrees Celsius and 5%carbon dioxide for 24 hours. Then collect the infected cells with a pipette and transfer them to a 15 milliliter conical tube.
Centrifuge the cells at 200 times G for five minutes. Remove the supernatant and add two milliliters of fresh KBM 5 0 2 medium. Replace the cells in the wells of a six well plate and incubate for 24 hours in a cell culture incubator.
To recede the cells first thaw the basement membrane matrix solution at four degrees Celsius overnight dissolve 0.2 milliliters of the thought solution in 10 milliliters of DMM F 12 medium plate five milliliters of the basement membrane matrix solution into 100 millimeter dishes. Leave the plates at room temperature for at least 30 minutes to allow the matrix to coat the dish before seeding cells. Meanwhile, collect the SAI virus infected T cells in a 15 liter conical tube and centrifuge at 200 times G for five minutes.
Then resuspend the palate in one milliliter of fresh KBM 5 0 2 medium, and count the cells using a hemo cytometer after the 30 minute incubation period. Remove the basement membrane matrix solution from the two plates, then resuspend one times 10 to the fifth cells and separately one times 10 to the six cells into 10 milliliters of fresh M-T-E-S-R medium, a feeder cell free culture medium for ipsc. Pipette each cell suspension to a separate 100 millimeter plate.
Incubate the plate in a cell culture incubator. Changing the medium every other day after 20 to 30 days. Colonies that resemble embryonic stem cell colonies should appear.
Prepare six wall plates for IPSC expansion by incubating one milliliter of basement membrane matrix solution in each well for 30 minutes at room temperature. Meanwhile, view culture plates containing IPSC colonies under a stereo microscope and isolate individual colonies by scraping them with a 20 microliter pipette. Transfer each colony to a well and a 96 wall plate containing 20 microliters of M-T-E-S-R medium.
After transferring the colonies, add 200 microliters of M-T-E-S-R medium to each well and pipette up and down to disrupt the colony. After removing the basement membrane matrix solution from the six well plates transfer cells from an individual colony to each well then add two milliliters of M-T-E-S-R medium, incubate the cells in a cell culture incubator and change the medium every other day using feeder free culture and serum free media ipsc were generated from human peripheral T cells. Immunofluorescent staining revealed expression of typical pluripotent cell markers, including nano T three four SSEA four, TRA one 60, and TRA 180 1.
In these derived IPSE lines. While attempting this procedure, it's important to remember to perform all steps, taking into account all all the important sterility and bio safety considerations.
This protocol describes a method for generating induced pluripotent stem cells (iPSCs) from human peripheral T cells under feeder-free conditions using matrigel and Sendai virus vectors. This technique aims to enhance the safety and efficacy of iPSC applications in regenerative medicine.